About the Authors

Karin Neukam

karin.neukam@gmail.com

Affiliations Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain

José A. Mira

Affiliation Internal Medicine Service, Hospital Universitario de Valme, Seville, Spain

Antonio Collado

Affiliation Internal Medicine Department, Hospital Torrecárdenas, Almeria, Spain

Antonio Rivero-Juárez

Affiliation Internal Medicine Department, Hospital Torrecárdenas, Almeria, Spain

Patricia Monje-Agudo

Affiliations Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain

Josefa Ruiz-Morales

Affiliation Unit of Infectious Diseases, Hospital Universitario Virgen de la Victoria, Malaga, Spain

María José Ríos

Affiliation Unit of Infectious Diseases, Hospital Universitario Virgen de la Macarena, Seville, Spain

Dolores Merino

Affiliation Internal Medicine Service, Hospital Juan Ramón Jiménez. Huelva, Spain

Francisco Téllez

Affiliation Unit of Infectious Diseases, Hospital de La Línea de la Concepción, Cadiz, Spain

Inés Pérez-Camacho

Affiliation Unit of Tropical Medicine, Hospital Poniente, El Ejido, Spain

María Carmen Gálvez-Contreras

Affiliation Internal Medicine Department, Hospital Torrecárdenas, Almeria, Spain

Antonio Rivero

Affiliation Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Maimonides Institute for Biomedical Research (IMIBIC), University of Cordoba, Cordoba, Spain

Juan A. Pineda

Affiliation Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain

HEPAVIR SEG-HEP-2007 Study Group of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI)

Complete membership of the author group can be found in the Acknowledgments.

Competing Interests

K.N. has received lecture fees from Janssen-Cilag, Roche, Bristol-Meyers Squibb and Merck Sharp & Dohme and has received research support from Janssen-Cilag, Bristol-Meyers Squibb, Merck Sharp & Dohme, Gilead Sciences and Abbott Pharmaceuticals. A.R.J has received lecture fees from Bristol-Myers Squibb, Merck Sharp & Dohme, Pfizer, ViiV Healthcare and Roche. D.M. reports having received consultancy fees from Janssen Cilag, Merck Sharp & Dohme, Bristol-Myers Squibb, Gilead Sciences, AbbVie and ViiH Healthcare. A.C. reports having received consultancy fees from Janssen-Cilag, Merck Sharp & Dohme, Bristol-Myers Squibb, Gilead Sciences, Pfizer and AbbVie. A.R. reports having received consulting fees from GlaxoSmithKline, Bristol-Myers Squibb, Abbott Pharmaceuticals, Gilead Sciences, Merck Sharp & Dohme, Schering-Plough, Janssen-Cilag and Boehringer Ingelheim. He has received research support from GlaxoSmithKline, Roche, Bristol-Myers Squibb, Schering-Plough, Abbott Pharmaceuticals and Boehringer Ingelheim, and has received lecture fees from GlaxoSmithKline, Roche, Abbott Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, Janssen-Cilag, Boehringer Ingelheim and Schering-Plough. J.A.P. reports having received consulting fees from GlaxoSmithKline, Bristol-Myers Squibb, Abbott Pharmaceuticals, Gilead Sciences, Merck Sharp & Dohme, Schering-Plough, Janssen-Cilag and Boehringer Ingelheim. He has received research support from GlaxoSmithKline, Roche, Bristol-Myers Squibb, Schering-Plough, Abbott Pharmaceuticals and Boehringer Ingelheim, and has received lecture fees from GlaxoSmithKline, Roche, Abbott Pharmaceuticals, Bristol-Myers Squibb, Gilead Sciences, Merck Sharp & Dohme, Janssen-Cilag, Boehringer Ingelheim and Schering-Plough. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: KN JAM JAP. Performed the experiments: KN JAM AC ARJ PMA JRM MJR DM FT IPC MCGC AR JAP. Analyzed the data: KN JAM JAP. Contributed reagents/materials/analysis tools: KN JAM AC ARJ PMA JRM MJR DM FT IPC MCGC AR JAP. Wrote the paper: KN JAM AC ARJ PMA JRM MJR DM FT IPC MCGC AR JAP.